SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS
摘要
<p>The present invention belongs to the field of EPl receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EPl receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EPl receptor as well as to pharmaceutical compositions comprising them.</p>
申请公布号
WO2013149996(A9)
申请公布日期
2014.02.20
申请号
WO2013EP56884
申请日期
2013.04.02
申请人
ALMIRALL, S.A.;DRACONIS PHARMA, S.L.;LABORATORIOS DEL DR. ESTEVE, S.A.
